Age-related expression of MCP-1 and MMP-3 in mouse intervertebral disc in relation to TWEAK and TNF-α stimulation
✍ Scribed by Koji Fujita; Takashi Ando; Tetsuro Ohba; Masanori Wako; Nobutaka Sato; Yuki Nakamura; Yuko Ohnuma; Yasushi Hara; Ryohei Kato; Atsuhito Nakao; Hirotaka Haro
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 405 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0736-0266
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
This study was undertaken to investigate the age‐related differences of monocyte chemotactic protein‐1 (MCP‐1) and matrix metalloproteinase‐3 (MMP‐3) expression in mouse intervertebral disc (IVD) and to determine whether MMP‐3 plays a role in disc degeneration. Expression of MCP‐1 and MMP‐3 mRNA in mouse IVD was assessed by quantitative PCR. The ability of MCP‐1 and MMP‐3 expression in IVD to respond to TNF‐α or TWEAK stimulation was examined by quantitative PCR, WB, ELISA, and immunohistochemistry. IVD derived from MMP‐3‐deficient and wild‐type mice were compared using Safranin‐O staining and immunohistochemistry. mRNA levels of MCP‐1 and MMP‐3 in IVD significantly diminished and the ability of MCP‐1 or MMP‐3 expression to respond to TNF‐α or TWEAK stimulation was significantly reduced as age increased. IVD derived from 64‐week‐old wild‐type mice showed clearly diffuse proteoglycan loss by Safranin‐O staining and immunohistochemistry compared with younger mice. However, no loss of proteoglycan and typeII collagen were observed in IVD derived from 64‐week‐old MMP‐3‐deficient mice. MCP‐1 and MMP‐3 expression in mouse IVD showed age‐related decreases. The response to inflammation in IVD also displayed age‐related changes. Therefore, disc degeneration may vary with the patients' age and targeting MMP‐3 may be a possible future therapeutic strategy for disc degeneration. © 2011 Orthopaedic Research Society. © 2011 Orthopaedic Research Society Published by Wiley Periodicals, Inc. J Orthop Res 30:599–605, 2012